Discovery of a Novel Warhead against β-Secretase through Fragment-Based Lead Generation
Authors:
- 1 November 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (24) , 5903-5911
Abstract
Fragment-based lead generation was applied to find novel small-molecule inhibitors of β-secretase (BACE-1), a key target for the treatment of Alzheimer's disease. Fragment hits coming from a 1D NMR screen were characterized by BIAcore, and the most promising compounds were soaked into protein crystals to help the rational design of more potent hit analogues. Problems arising due to our inability to grow BACE-1 crystals at the biologically relevant pH at which the screen was run were overcome by using endothiapepsin as a surrogate aspartyl protease. Among others, we identified 6-substituted isocytosines as a novel warhead against BACE-1, and the accompanying paper in this journal describes how these were optimized to a lead series of nanomolar inhibitors.1Keywords
This publication has 30 references indexed in Scilit:
- Druggability Indices for Protein Targets Derived from NMR-Based Screening DataJournal of Medicinal Chemistry, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Ligand efficiency: a useful metric for lead selectionDrug Discovery Today, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Proteolytic Activation of Recombinant Pro-memapsin 2 (Pro-β-secretase) Studied with New Fluorogenic SubstratesBiochemistry, 2000
- Structure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with InhibitorScience, 2000
- The Design of Leadlike Combinatorial LibrariesAngewandte Chemie International Edition, 1999
- MOLREP: an Automated Program for Molecular ReplacementJournal of Applied Crystallography, 1997
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D Structural Biology, 1994
- A new method for predicting binding affinity in computer-aided drug designProtein Engineering, Design and Selection, 1994